Evaluating the Vitamin K2 Status of Calcium-based Stone Formers
Sponsored by Lawson Health Research Institute
About this trial
Last updated 2 years ago
Study ID
Status
Type
Placebo
Accepting
Trial Timing
Ended 2 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Male/Female, 18 - 65 years old
- No self-reported kidney stones during their lifetime (controls)
- Ultrasound examination confirming absence of kidney stones (controls)
- Have had at least 1 incidence of a clinically confirmed calcium-based kidney stone in the last 12 months (stone formers)
- Ability to collect a clean catch urine sample
- Prescription and over-the-counter drugs unchanged for ≥30 days
- Willingness to provide medical information, blood, urine, and fecal samples
Exclusion Criteria
- Current, or within 30 days, use of antibiotics or antifungals
- Current, or within 30 days, use of vitamin K antagonists
- Current probiotic use or any use within 14 days of screening sample collection should be recorded
- A history or currently undergoing immunosuppressive drug therapy, chemotherapy, or radiation therapy 2021-06-29 1.0 Page 4 of 6
- Fecal incontinence
- History of disorder with abnormal calcium regulation such as hyperparathyroidism, active malignancy, or osteoporosis.